WHO ICTRP trial
Avelumab Rollover Study
EUCTR2018-003711-21-BE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2018-003711-21-BE |
|---|---|
| Public title | Avelumab Rollover Study |
| Scientific title | An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants from Multiple Avelumab (MSB0010718C) Clinical Studies - Avelumab Program Rollover Study |
| Primary sponsor | Merck KGaA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;Taiwan;Spain;Russian Federation;Chile;Colombia;Italy;France;Peru;Denmark;South Africa;Korea, Republic of;Czechia;Turkey;United… |
| Conditions | Solid Tumors MedDRA version: 21.1 Level: LLT Classification code 10065252 Term: Solid tumor System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Trade Name: Bavencio Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: AVELUMAB CAS Number: 1537032-82-8 Other descriptive name: Anti-PD-L1 Concentration unit: mg/ml milligram(s)/millilitre Concentration type… |
| Registration date | Feb 15, 2019 |
| Target size | 312 |
| Secondary IDs | MS100070_0176;2018-003711-21-DE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: